Viatris Inc.

Filed a patent for "medication injection device and method" on Tue, February 21, 2023

Filed a patent for "combination for use for the treatment of hypercholesterolemia, hyperlipidemia, cardiovascular disease and metabolic syndrome" on Thu, January 18, 2024

Filed a patent for "solid oral pharmaceutical compositions including alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor" on Thu, August 15, 2024

Filed a patent for "devices for injecting medicaments and methods of use" on Thu, June 29, 2023

Filed a patent for "pharmaceutical composition comprising meloxicam" on Fri, May 5, 2023

Filed a patent for "plant extract composition for the treatment of cardiovascular and metabolic diseases" on Thu, March 2, 2023